Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Pathol Res Pract. 2010 Dec 15;206(12):846-50. doi: 10.1016/j.prp.2010.07.007. Epub 2010 Sep 16.
Ulcerative colitis (UC) complicated by colonic lymphoma is rare, although UC is often accompanied by adenocarcinoma of the colon. A concurrent existence of adenocarcinoma and lymphoma in a patient with UC is extremely rare, and has not yet been analyzed at the molecular level. We report a 64-year-old female patient with concomitant adenocarcinoma and diffuse large B-cell lymphoma (DLBCL) in the colon of UC. The genetic changes in these two neoplasms were analyzed. The colon adenocarcinomas had a mutation in MSH6 gene, DNA methylation in CDKN2A gene, and increased microsatellite instability (MSI), although these genetic changes were not recognized in either DLBCL or non-neoplastic UC mucosa. The DLBCL was diagnosed as primary colonic lymphoma, and confirmed Epstein-Barr virus (EBV) infection. The adenocarcinomas and the non-neoplastic UC mucosa were EBV-negative. Our case presented here clearly shows that the development of adenocarcinoma and lymphoma in the colon with UC was caused by individual mechanisms.
溃疡性结肠炎(UC)并发结肠淋巴瘤较为罕见,尽管 UC 常伴有结肠癌。UC 患者同时存在腺癌和淋巴瘤极为罕见,尚未在分子水平上进行分析。我们报告了一例 64 岁女性 UC 患者合并结肠腺癌和弥漫性大 B 细胞淋巴瘤(DLBCL)。分析了这两种肿瘤的遗传变化。结肠腺癌存在 MSH6 基因突变、CDKN2A 基因甲基化和微卫星不稳定性(MSI)增加,而在 DLBCL 或非肿瘤性 UC 黏膜中均未发现这些遗传变化。DLBCL 被诊断为原发性结肠淋巴瘤,并证实 EBV 感染。腺癌和非肿瘤性 UC 黏膜均为 EBV 阴性。本病例清楚地表明,UC 合并结肠腺癌和淋巴瘤的发生是由不同的机制引起的。